Cross‐company collaboration to leverage analytics for clinical quality and accelerate drug development: The IMPALA industry group-Reference-Cited by-同舟云学术

Cross‐company collaboration to leverage analytics for clinical quality and accelerate drug development: The IMPALA industry group

Published:2021-07-11 Issue:8 Volume:10 Page:799-803
ISSN:2163-8306
Container-title:CPT: Pharmacometrics & Systems Pharmacology
language:en
Short-container-title:CPT Pharmacometrics Syst. Pharmacol.

Author:

Ménard Timothé¹^ORCID,Young Kyle²,Siegel Laura³,Emerson Jennifer⁴,Studt Robert⁵,Sidor Leslie⁶,Khordi Daniel,Donohue David,Sliwowska Maria,Ring Stephanie,

Affiliation:

1. F. Hoffmann‐La Roche AG Basel Switzerland

2. Merck & Co Kenilworth New Jersey USA

3. GlaxoSmithKline (GSK) Collegeville Pennsylvania USA

4. Boehringer Ingelheim Pharma GmbH & Co KG Biberach an der Riss Germany

5. Johnson & Johnson Spring House Pennsylvania USA

6. Biogen Cambridge Massachusetts USA

Publisher

Wiley

Subject

Pharmacology (medical),Modeling and Simulation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/psp4.12677

Reference10 articles.

1. Guideline for Good Clinical Practices – International Conference of Harmonizationhttps://database.ich.org/sites/default/files/E6_R2_Addendum.pdf. Accessed May 3 2021.

2. Guideline on Good Pharmacovigilance Practices (GVP).Module I—Pharmacovigilance systems and their quality systems;2012https://www.ema.europa.eu/en/documents/scientific‐guideline/guideline‐good‐pharmacovigilance‐practices‐module‐i‐pharmacovigilance‐systems‐their‐quality‐systems_en.pdf. Accessed May 3 2021.

3. AlsumidaieM.Clinical Trial Quality Concerns Arise Amidst COVID. Applied Clinical Trials;2020.https://www.appliedclinicaltrialsonline.com/view/clinical‐trial‐quality‐concerns‐arise‐amidst‐covid. Accessed May 3 2021.

4. Leveraging analytics to assure quality during the Covid-19 pandemic - The COVACTA clinical study example

5. Letter to the Editor: New Approaches to Regulatory Innovation Emerging During the Crucible of COVID-19

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ensuring Quality in Clinical Research: The Impact of Quality Assurance and Quality Control in the Field of Good Clinical Practice;2024-08-23

2. An Open-Source R Package for Detection of Adverse Events Under-Reporting in Clinical Trials: Implementation and Validation by the IMPALA (Inter coMPany quALity Analytics) Consortium;Therapeutic Innovation & Regulatory Science;2024-04-02

3. An Open Source R Package for Detection of Adverse Events Under-Reporting in Clinical Trials - Implementation and Validation by the IMPALA (Inter coMPany quALity Analytics) Consortium;2024-01-17

4. An Open Source R Package for Detection of Adverse Events Under-Reporting in Clinical Trials - Implementation and Validation by the IMPALA (Inter coMPany quALity Analytics) Consortium;2023-12-20

5. An Open Source R Package for Detection of Adverse Events Under-Reporting in Clinical Trials - Implementation and Validation by the IMPALA (Inter coMPany quALity Analytics) Consortium;2023-10-30